Deverra Therapeutics

Deverra Therapeutics

Biotechnology, 1600 Fairview Ave E Ste 300, Seattle, Washington, 98102, United States, 11-50 Employees

deverratx.com

  • LinkedIn

Who is DEVERRA THERAPEUTICS

Deverra Therapeutics is a clinical stage biotechnology company dedicated to the development of allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with ...

Read More

map
  • 1600 Fairview Ave E Ste 300, Seattle, Washington, 98102, United States Headquarters: 1600 Fairview Ave E Ste 300, Seattle, Washington, 98102, United States
  • 2020 Date Founded: 2020
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 3721 | NAICS Code: 522291 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from DEVERRA THERAPEUTICS

Deverra Therapeutics Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Deverra Therapeutics

Answer: Deverra Therapeutics's headquarters are located at 1600 Fairview Ave E Ste 300, Seattle, Washington, 98102, United States

Answer: Deverra Therapeutics's official website is https://deverratx.com

Answer: Deverra Therapeutics's revenue is $1 Million to $5 Million

Answer: Deverra Therapeutics's SIC: 3721

Answer: Deverra Therapeutics's NAICS: 522291

Answer: Deverra Therapeutics has 11-50 employees

Answer: Deverra Therapeutics is in Biotechnology

Answer: Deverra Therapeutics contact info: Phone number: Website: https://deverratx.com

Answer: Deverra Therapeutics is a clinical stage biotechnology company dedicated to the development of allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases. The company has an exclusive license to a proprietary stem cell expansion and directed-differentiation platform from the Fred Hutchinson Cancer Research Center based on more than 20 years of federally funded research and data from 5 clinical trials. This platform can be used to generate a range of unmodified and modified immune cells to treat patients with cancer and infectious diseases.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access